Work

Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-110142

Authors: Nasheed Hossain, Bita Sahaf, Matthew Abramian, Jay Y. Spiegel, Katie Kong, Stephen Kim, Sharon Mavroukakis, Jean Oak, Yasodha Natkunam, Everett H Meyer, Matthew J. Frank, Steven A Feldman, Steven R. Long, Haiying Qin, Terry J. Fry, Lori S Muffly, Crystal L. Mackall, David B. Miklos

Institutions: Stanford Medicine, Stanford University, National Cancer Institute, Center for Cancer Research, University of Colorado Anschutz, University of Colorado Denver

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2906492823

Cites:

Cited by: 60

Related to: 10